Physician profile
Julia Lupa
NPI 1053369249
$2,467.99
in general payments reported to CMS, 2019-2025
18 companies · $357 in 2025
The $357 reported for 2025 was more than what 79% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $678 · 2022: $591 · 2023: $336 · 2024: $507 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.19 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $480.31 | 2021-2025 | |
| Astellas Pharma US INC | $433.40 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $432.03 | 2021-2023 | |
| Exeltis, USA INC. | $222.78 | 2021-2024 | Slynd |
| Amgen INC. | $173.55 | 2021-2024 | Evenity, Prolia |
| Therapeuticsmd, INC. | $137.17 | 2021-2022 | |
| Organon LLC | $99.16 | 2021-2025 | Nexplanon |
| Myovant Sciences INC. | $94.60 | 2021-2022 | |
| Millicent US INC | $83.58 | 2021-2025 | Intrarosa, Femlyv, Femring |
| Sumitomo Pharma America, INC. | $64.32 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $57.91 | 2022-2024 | |
| Exact Sciences Corporation | $52.87 | 2024-2025 | Cologuard Collection Kit |
| Channel Medsystems, INC. | $32.86 | 2023 | |
| Mylan Pharmaceuticals INC. | $30.69 | 2021 | |
| Hologic Sales and Service, LLC | $25.61 | 2024 | Aptima |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $18.89 | 2021 | |
| Scynexis, INC. | $16.33 | 2022 | |
| Avion Pharmaceuticals | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Lupa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.